Recognition of pathogen-associated molecular patterns (PAMPs) by their receptors results in the production of inflammatory mediators that act to control initial infection and mobilize elements of the innate immune system 1,2 . PAMP recognition also facilitates optimal development of adaptive immune responses by activating antigen-presenting cells (APCs) while ensuring that enhanced antigen-specific responses occur only when a pathogen is present 3,4 . However, although the role of innate immune recognition in shaping adaptive immune responses is established, a role for adaptive immune cells in regulation of innate inflammation is largely unexplored.
(HNT cells) 13 . We generated memory cells in vivo by transferring naive HNT cells to host mice and then infected the mice with a sublethal dose of influenza A/PR8. We allowed the virus to clear and memory cells to develop for at least 40 d before reisolation. As influenzaspecific CD4 + T cell responses are largely T H 1 in nature 6 , we also generated memory cells in vitro by resting T H 1-polarized effectors for 3 d in the absence of cytokine and antigen. We showed previously that in vitro-generated memory cells are virtually identical to longterm in vivo memory cells, as assessed by broad criteria 14 . We found that transfer of either in vivo-or in vitro-generated memory cells induced similar increases in IICs (Fig. 1b) , and the expression remained elevated for several days in the lung and serum (Supplementary Fig. 3 ). These results demonstrate that memory CD4 + T cells present in otherwise naive hosts drive enhanced IIC responses with comparable kinetics to those observed after influenza challenge of primed mice. Fig. 4 ) and could thus account for the increased IFN-γ amounts observed upon influenza challenge. To determine whether memory cells stimulate IFN-γ production from other sources, we generated T H 1-polarized memory cells recognizing ovalbumin (OVA) from IFN-γ-deficient, TCR-transgenic OT-II cells, transferred them to C57BL/6 hosts and infected the mice with virus expressing OVA (A/PR8-OVA II ) 15 . Memory cells induced elevated IFN-γ on days 2 and 3 after infection (Fig. 2a) , indicating IFN-γ production from sources other than donor cells. Employing IFN-γ reporter (Yeti) mice as hosts 16 , we observed increased IFN-γ (enhanced yellow fluorescence protein (EYFP)) signal from natural killer cells and γδ + T cells but not from MHC-II + , CD8 + or Gr-1 + cells, indicating contributions from multiple innate populations to the enhanced IIC response (Fig. 2b) . In support of this conclusion, memory cell transfer to host mice carrying the severe combined immune deficiency (SCID) mutation drove an elevated IIC response comparable to that in wild-type (WT) hosts upon influenza challenge (Supplementary Fig. 5 ).
Memory cells upregulate IICs independently of T H 1 cytokines T H 1 but not other subsets of memory CD4 + T cells produce abundant IFN-γ upon stimulation (Supplementary
Because IFN-γ is a potent regulator of inflammation 17, 18 , we evaluated its role in driving enhanced IIC response. We transferred memory cells to IFN-γ receptor-deficient (Infgr −/− ) or WT hosts and observed a similar IIC response, with the exception of CXCL9 and CXCL10 (Fig. 2c) . As T H 1 memory cells also produce TNF-α and CCL3 ( Supplementary  Fig. 4 ), we used TNF-α receptor-deficient (Tnfrsf1ab −/− ) and Ccr5 −/− hosts and again observed a similar upregulation of the IIC response (Fig. 2c) . These results indicate that memory CD4 + T cells enhance a broad spectrum of IICs in an IFN-γ-, TNF-α-and CCL3-independent manner, but they are consistent with a requirement for IFN-γ for optimal CXCL9 and CXCL10 induction 19, 20 .
To investigate how enhanced IIC responses affect the course of influenza infection, we measured viral titers. Compared to transfer of naive OT-II cells, memory transfer resulted in significantly lower titers in WT, Infgr −/− , Tnfrsf1ab −/− and Ccr5 −/− mice on day 3 (data not shown) and day 4 after infection with A/PR8-OVA II (Fig. 2d) . These results demonstrate that enhanced IIC responses mediated by memory CD4 + T cells correlate with viral control after influenza infection. (a) IIC concentrations 40 h after challenge in naive C57BL/6 mice, or mice primed with influenza A/Phil 60 d before treatment, treated with isotype, CD4-or Thy1.2-depleting antibody before influenza A/PR8 challenge (n = 5 mice per group). (b) IIC concentrations after bulk CD4 + T cells were isolated from naive or influenza A/PR8-primed mice (polyclonal memory) and equal numbers transferred to naive hosts or, alternatively, naive or in vivo-or in vitro-generated HNT memory cells were adoptively transferred to naive BALB/c hosts. All recipients were challenged with influenza A/PR8 and lung homogenates assessed for IIC after 40 h (n = 5 mice per group). Dotted lines in all figures represent levels of IICs in the absence of infection. Error bars indicate s.d.; *P < 0.05, **P < 0.005 (one-way analysis of variance (ANOVA) followed by Bonferroni's post hoc test).
Lung T H 1 and T H 17 cells upregulate IICs and viral control
As T H 1-polarized memory cells upregulate IICs and viral control independently of major T H 1 cytokines, we next tested the ability of other subsets of memory CD4 + T cells to mediate the same response. We transferred T H 1, T H 2, T H 17 or unpolarized (T H 0) memory HNT cells to naive mice and infected them with influenza A/PR8. T H 1 and T H 17 memory cells caused similar enhanced IIC concentrations at 40 h after infection, whereas T H 2 transfer increased only IL-13 and CCL2 concentrations, and T H 0 transfer had little impact on most IICs measured (Fig. 3a) . Strikingly, T H 1 and T H 17, but not T H 2 or T H 0, transfer also lowered viral titers at days 3 and 4 after infection (Fig. 3b) . These results support the hypothesis that the IIC response induced by T H 1 and T H 17 memory CD4 + T cells is responsible for protection and are consistent with studies demonstrating that T H 1-and T H 17-but not T H 2-polarized HNT responses protect unprimed mice against lethal influenza challenge 21, 22 .
To understand the mechanisms leading to enhanced IIC responses, we examined the fate of transferred HNT cells 40 h after influenza infection. We detected similar numbers of naive and memory cells in all organs tested (Fig. 4a) , neither population had undergone division as assessed by carboxyfluorescein succinimidyl ester (CFSE) analysis, and both had upregulated expression of the early activation marker CD69 in draining lymph nodes but not the spleen (Fig. 4b) . In the lung, however, only memory cells upregulated CD69, and they did so in infected but not uninfected mice (Fig. 4b) . To determine whether enhanced IIC production requires memory cell activation in the draining lymph node before extravasating to the lung, or whether activation in the lung 23 is sufficient, we used lymphotoxin-deficient (Lta −/− ) hosts that lack peripheral lymph nodes 24 with or without splenectomy. There was similar enhancement of IIC production in both sham-treated and splenectomized Lta −/− mice compared to WT mice after transfer of memory CD4 + T cells (Fig. 4c) , suggesting that interactions in the lung are sufficient to enhance IIC production and control virus (Fig. 4d) .
Cellular mechanism of induction of IICs by memory T cells
We next studied the cellular interactions required for IIC induction and viral control. To determine whether there is a need for cognate antigen recognition, we transferred OT-II memory cells to host mice and infected them with either influenza A/PR8 or influenza A/PR8-OVA II . OVA-specific cells drove increased IIC production (data not shown) and lowered viral titers after infection with A/PR8-OVA II , which expresses the antigen recognized by OT-II cells, but not A/PR8, which does not (Fig. 5a ). To test whether antigen recognition on lung epithelial cells, which upregulate MHC-II upon infection 25 , or on CD11c + APCs is essential, we transferred memory OT-II cells to MHC-II-deficient (H2-Ab1 −/− ) hosts or to hosts expressing MHC-II only on CD11c + cells (CD11c Tg.H2-Ab1 −/− ) 26 . There was no induction of IIC production or viral control in H2-Ab1 −/− hosts, but we observed both in CD11c Tg.H2-Ab1 −/− mice ( Fig. 5b,c) , indicating that antigen recognition is crucial, and that presentation by MHC-II + CD11c + cells is sufficient, for memory CD4 + T cells to enhance IIC production and control virus.
To investigate whether memory cells also regulate APC function upon influenza challenge, we assessed the number and activation status of CD11c + cells in the lung. We found similar numbers of CD11c + cells in recipients of memory or naive CD4 + T cells after infection (Fig. 5d) , but memory T cell transfer markedly enhanced the activation of CD11c + cells, as shown by upregulation of MHC-II and CD40 expression (Fig. 5e) . These markers were also upregulated when memory, but not naive, HNT cells were cultured in vitro with bone marrow-derived dendritic cells (DCs) and peptide for 40 h (Fig. 5f) . Memory cells also induced secretion of higher amounts of several IICs from DCs as compared to culture with naive cells (Fig. 5g) , and we observed similar results with the alveolar macrophage line MH-S (data not shown). To determine whether direct cell contact was required for DC activation, we separated memory cells from DCs in a transwell system and stimulated them with CD3-specific antibody to induce cytokine production. DCs separated by the transwell did not upregulate MHC-II or CD40 (Fig. 5f) , and we did not observe elevated levels of IICs (Fig. 5g) . These results show that memory CD4 + T cells deliver cell contact-dependent signals that enhance the activation of the APCs and drive their production of several IICs.
Memory CD4 + T cells amplify IICs independently of PAMPs
Flu viruses trigger Toll-like receptors 27, 28 and drive type I IFN production through retinoid-inducible gene-1 (ref. 29) . Influenza-induced effects through these pathways might synergize with or facilitate those mediated by memory CD4 + T cells, leading to enhanced IIC production and viral control. We transferred memory OT-II cells to IFN-α/β receptor-deficient (Ifnar2 −/− ), myeloid differentiation factor-88 (MyD88)-and Toll-IL-1 receptor domain-containing adaptor inducing interferon-β (TRIF, encoded by Ticam1)-deficient (Myd88 −/− ;Ticam1 −/− ) or WT hosts and infected the mice with influenza A/PR8-OVA II . We found similarly enhanced IIC production and decreased viral titers in all hosts 40 h after challenge (Fig. 6a,b) , suggesting that these major PAMP receptor pathways are not involved in memory CD4 + T cell-mediated enhancement.
Given this independence, we asked whether the enhanced IIC production could be induced by protein antigen in the absence of infection. We administered lipopolysaccharide (LPS)-free OVA protein intranasally and still found broad increases in IICs in the presence of memory OT-II cells (Fig. 6c) . Moreover, when we administered LPS-free OVA together with influenza A/PR8, the presence of memory cells specific for OVA resulted in lower viral titers, demonstrating that although antigen recognition is required for enhanced IIC production, the impact of IICs and viral control occurs by an indirect mechanism no longer requiring T cell recognition (Fig. 6d) . To test whether viral control correlates with a transient burst of IICs or whether memory cells induce a longer-lived protective state, we transferred memory cells to mice and administered LPS-free OVA on the same day (day 0) and infected the mice with influenza A/PR8 7 d later. When infection was delayed, OVA-specific memory cells provided no protection (Fig. 6d) . These results show that memory CD4 + T cells induce IICs and that this or other aspects of their activation results in nonspecific induction of a transient protective state that acts during the initial phases of infection.
DISCUSSION
Here we demonstrate a previously undescribed form of direct control by memory CD4 + T cells over innate inflammatory responses. We show that memory CD4 + T cells recognizing antigen presented by APCs results in the activation of the latter cells and enhanced production of a broad range of IICs from multiple cellular sources independently of memory cell production of major T H 1-associated cytokines. Most notably, we show this response is strongly correlated with control of virus during the early phases of pathogen challenge.
How might this mechanism contribute to heterosubtypic responses against influenza? Our previous studies have shown that although survival of influenza-primed mice after heterosubtypic challenge is CD8 + T cell dependent, CD4 + T cell depletion results in severely compromised protection 5 . We therefore suggest that early viral control provided by memory CD4 + T cells may be mediated by enhanced IIC production that may provide a key restraint on viral replication before the development of substantial effector CD8 + T cell responses that ultimately clear virus. Furthermore, because innate responses also regulate the development of adaptive immunity, we speculate that CD8 + T cell and B cell responses against influenza may be considerably altered or enhanced through the action of virus-specific memory CD4 + T cells, in particular through the earlier activation of APC populations. In support of this hypothesis, we show that the protective impact of enhanced IIC production itself is transient, which may help to explain the failure of memory CD4 + T cells alone to protect against supralethal heterosubtypic challenge 5 .
Previous studies have suggested that naive CD4 + T cells or uncharacterized effectors and memory phenotype cells obtained from unmanipulated mice dampen inflammation, thereby preventing pathology 30, 31 . We found that only well-polarized T H 1 and T H 17, but not T H 2 or unpolarized memory cells, upregulated IICs. Our results thus highlight the ability of polarized CD4 + T cells to differentially affect IICs. We speculate that the activation status and polarization of T cells, as well as the nature of the challenge and the context of antigen encounter, may all influence regulation of IICs. In agreement with recent studies, we show that augmentation of IICs during influenza infection can be a key element of a protective response 32, 33 , and, because T H 2 and T H 0 cells neither protect nor induce IICs, we suggest that tempering the upregulation of acute inflammation IICs may be deleterious. We envisage several teleological benefits for memory CD4 + T cell induction of IICs. First, this mechanism may represent a major failsafe for eliciting optimal inflammation and rapid containment of infection in situations where pathogens evade PAMP recognition 34 . Second, because memory cells can be induced by low concentrations of antigen and co-stimulation, they may activate innate effector mechanisms before pathogen levels are sufficient to trigger robust responses through PAMP recognition. Independent recruitment of IICs by memory cells may also counteract strategies to dampen innate responses used by pathogens, including influenza 35 . Finally, cytokines such as IL-12 and IL-6 are key in the activation of CD8 + T cells and B cells 36, 37 , and memory CD4 + T cell upregulation of IICs may thus facilitate optimal development of adaptive responses at later stages after infection.
The protective versus detrimental roles of individual IICs during influenza infection is not well understood 38 . Our results suggest that IFN-γ, TNF-α, CCL3, CXCL-9 and CXCL-10 are not required for early viral control. In contrast, protective roles for IL-1, IL-6 and IL-12 have been previously reported [39] [40] [41] , and these factors were markedly upregulated by protective memory CD4 + T cells. Thus, we suggest that it is most likely that the protective impact of memory CD4 + T cells is not dependent on any one element of IICs alone, but a combination of many. Further studies will be required to determine the degree to which these factors, and others, alone or in combination contribute to viral control.
Our results support the hypothesis that cognate recognition of antigen on CD11c + APC by memory CD4 + T cells is the initiating step in driving IIC production from various innate cells. Most likely, several of the IICs assayed are produced by multiple cellular populations. For example, alveolar macrophages produce robust amounts IL-1, IL-6 and TNF-α; alveolar epithelial cells can produce IL-1, TNF-α and CCL2; natural killer cells produce IFN-γ, TNF-α and CCL3; and activated DCs are sources IL-6, IL-12, TNF-α, CXCL10, and type I IFN 36,42-45 . Our observations of enhanced levels of many IICs from DCs and alveolar macrophages stimulated in vitro, combined with observations of multiple cellular sources of IFN-γ in vivo, support the hypothesis that the initial activation of APCs is sufficient to initiate a cytokine and chemokine cascade that ultimately results in viral control 46 . Defining the crucial signals involved in this process will require further study, although our preliminary experiments have ruled out roles for the co-stimulatory molecules CD28, CD40 ligand, OX40 and inducible co-stimulator (data not shown).
Of note, very few donor memory T cells (thousands) are seen in the lung in these studies, yet these small numbers are sufficient to induce IIC production even when induced by low levels of nonreplicating antigen. We speculate that this unique mechanism of IIC upregulation could help explain why memory CD4 + T cells have been implicated in several models of autoimmunity including diabetes, experimental autoimmune encephalomyelitis and collagen-induced arthritis [47] [48] [49] . Further studies will need to determine the full risks and benefits of IICs induced by memory CD4 + T cells in the absence of PAMP recognition.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturemedicine/. Naive and memory CD4 T cell isolation. Naive CD4 + T cells were obtained from pooled spleen and lymph nodes of unimmunized mice ,as previously described 14 . T H 0, T H 1, T H 2 and T H 17 effectors were generated from naive TCR-transgenic CD4 + T cells as previously desribed 14, 22 , and in vitro-generated memory cells were generated from effectors as previously described 14 . In some experiments, CD4 + T cells were labeled with CFSE.
Polyclonal influenza-specific memory CD4 T cells were enriched by MACS purification (Miltenyi) of bulk CD4 + T cells from mice primed 60 d previously with influenza A/PR8. In vivo-generated memory HNT cells were obtained by first transferring naive HNT cells to nude hosts, which were then infected with a sublethal dose of influenza A/PR8. We isolated donor HNT cells after 40-60 d via CD4 + MACS, after host mice had completely cleared virus. The purity of Vβ8.3 + Thy1.1 + CD4 + cells was determined by flow cytometry.
Adoptive T cell transfers and T cell depletion. Naive or memory cells were adoptively transferred in 200 µl PBS by intravenous injection to naive hosts. In all experiments, mice received equal numbers of naive and memory CD4 + T cells (5 × 10 6 TCR-transgenic or 1 × 10 7 polyclonal cells).
In some experiments, mice were given 500 µg of either CD4-depleting (GK1.5) or Thy1.2-depleting (30H12) antibody via intraperitoneal injection (Bio x Cell).
Virus stocks, quantification of viral titer, ovalbumin protein and infections.
Influenza A/PR8 (H1N1) virus was produced in the allantoic cavity of embryonated hen eggs from virus stocks originating at St. Jude Children's Hospital and characterized by a core facility at the Trudeau Institute. A/Philippines (H3N2), obtained from S. Epstein, and engineered virus A/PR8-OVA II obtained from P. Doherty, were prepared similarly.
Mice were infected intranasally under light isoflurane anesthesia (Webster Veterinary Supply) with 50 µl of virus in PBS. In some experiments, mice first received a 500 half-maximal embryonic infectious dose (EID 50 (about 0.1half-maximal lethal dose (LD 50 ))) of priming virus 30-60 d before heterosubtypic challenge. All challenge doses of virus were 10,000 EID 50 (about 2 LD 50 ). Viral titers were determined by quantification of viral RNA as previously described 22 , and the number of copies of the acidic polymerase mRNA per lung was calculated.
LPS-free whole OVA protein was a generous gift from T. Moran. Cell culture. Naive or memory HNT CD4 + T cells, 5 × 10 4 per well, were cultured in vitro in Costar 24-well plates (Corning) in the absence or presence of HNT peptide with 1 × 10 5 bone marrow-derived DCs, prepared as previously described 50 . Alternatively, naive and memory CD4 + T cells were stimulated with CD3-specific antibody and were cultured with bone marrow-derived DCs present either in the bottom of the well or within transwell inserts (0.4 µm).
Flow cytometry. Mice were killed followed by exsanguination achieved by perforation of the abdominal aorta, and lungs were perfused by injecting 10 ml of PBS in the left ventricle. Single-cell suspensions were prepared from lungs, spleen and mediastinal lymph nodes by mechanical disruption and passage through a nylon membrane.
Flow cytometry was performed as previously described 14 with allophycocyanin-labeled Thy1.1-specific (OX-7) antibody, allophycocyaninThy1.2-specific (53-2.1) antibody (both eBiosciences), PerCP-labeled CD4-specific (RM4.5) antibody or phycoerythrin-labeled Vβ8.3-specific (1B3.3) antibody (both Pharmingen) to identify donor T cells. Phycoerythrin-labeled CD69-specific (H12F3) antibody (Pharmingen) and isotype controls were used for phenotype analysis. Analysis was performed with Becton Dickson FACS Scan (BD Biosciences) and FlowJo (Tree Star) software.
Detection of inflammatory cytokines and chemokines. Lungs were collected and homogenized in RPMI 1640 medium supplemented with 2mM l-glutamine (Invitrogen), 100 international units penicillin, 100 µg ml −1 streptomycin (MediaTech), 10 mM HEPES (Research Organics), 50 µM 2-mercaptoethanol (Sigma-Aldrich) and 7.5% FBS (Hyclone).
Concentrations of cytokines and chemokines in lung homogenates, serum and culture supernatants were determined with mouse multiplex luminex kits (Invitrogen) read on a Luminex 100 reader (Luminex). Concentrations of cytokines and chemokines in unprimed mice are represented by dotted lines in all figures, as we generally observed no significant differences in levels of protein in unprimed mice of different strains, WT values are depicted.
Statistical analyses. Unpaired, two-tailed, Student's t tests, ∝ = 0.05, were used to assess whether the means of two normally distributed groups differed significantly. The Welch-correction was applied when variances were found to differ. One-way ANOVA analysis with Bonferroni's multiple comparison post-test was used to compare multiple means. Significance is indicated as *P < 0.05, **P < 0.005 and ***P < 0.001. All error bars represent the s.d.
